Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:07 AM
Ignite Modification Date:
2025-12-25 @ 5:07 AM
NCT ID:
NCT07008027
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of acute lymphoblastic leukemia, lymphoblastic lymphoma, or mixed phenotype acute leukemia
* Enrolled on INITIALL and no more than 10 days after initiation of post-INITIALL therapy
* Post-INITIALL therapy is:
* Standard of Care (SOC)/Non Protocol Treatment Plan (NPTP) as per Total therapy or
* SJALL23T and not scheduled to receive venetoclax
Exclusion Criteria:
* Inability or unwillingness of research participant or legal guardian/representative to give written informed consent.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT07008027
Study Brief:
Protocol Section:
NCT07008027